Daniela Weiler

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Top Venues

European journal of nuclear medicine and molecular imaging

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Daniela Weiler, Maria Del Sol Pérez Lago
Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma. European journal of nuclear medicine and molecular imaging (2024)
Daniela Weiler, Maria Del Sol Pérez Lago
Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma. European journal of nuclear medicine and molecular imaging 51 (11) (2024)
Lori J Wirth, Marcia S Brose, Vivek Subbiah, Francis Worden, Benjamin J Solomon, Bruce Robinson, Julien Hadoux, Pascale Tomasini, Daniela Weiler, Barbara Deschler-Baier, Daniel Shao-Weng Tan, Patricia Maeda, Yan Lin, Ravinder Singh, Theresa Bayt, Alexander E Drilon, Philippe Alexandre Cassier
Durability of Response With Selpercatinib in Patients With RET -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Daniela Weiler, Maria Del Sol Pérez Lago
Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma. European journal of nuclear medicine and molecular imaging 51 (11) (2024)